Evercore ISI raises Invesco stock price target on solid flows By Investing.com

Evercore ISI raised Invesco's price target to $28 from $27 while keeping an In Line rating, citing a strong quarter with $1.74 billion of revenue versus $1.27 billion expected and $22 billion of net long-term inflows. Q1 2026 revenue beat consensus by 37.01%, adjusted operating margin reached 34.5%, and operating leverage improved by 300 bps, though EPS of $0.57 slightly missed the $0.58 estimate. The stock also has a 3.3% dividend yield and a four-year dividend growth streak, but remains described as overvalued at current levels.

Analysis

IVZ is turning into a cleaner operating leverage story than a pure AUM beta trade: the mix shift toward ETFs, international, and multi-asset suggests the firm is harvesting growth in segments with better fee durability while letting lower-quality active equity runoff do some of the margin repair. The hidden positive is that this kind of portfolio cleanup can keep comp and distribution costs from rising as fast as inflows, which matters more than headline revenue surprises for valuation rerating.

The market may still be underestimating how much of the current margin expansion is cyclical versus structural. If headcount has already been reset and the product mix remains tilted to lower-volatility inflows, incremental upside to operating margin could persist for 2-3 quarters even if markets stay rangebound; that would support a higher dividend-growth narrative and reduce the probability of multiple compression. The flip side is that a single quarter of strong flows can be noisy in an asset manager, so the stock is vulnerable if ETF momentum or China-related inflows normalize.

Consensus seems to be treating IVZ as fairly valued because it has already re-rated, but that misses the optionality from continued active runoff improving the earnings base faster than top-line growth would imply. The contrarian risk is that investors extrapolate recent operating leverage into a secular trend when, in reality, fund flows can reverse quickly if risk assets de-rate or if ex-China emerging markets underperform. In that scenario, IVZ can give back a meaningful portion of recent gains within 1-2 quarters even without a dramatic change in fundamentals.

Key Decisions for Investors

• Long IVZ for 1-3 months on any pullback toward the low-$25s; thesis is continued operating leverage and dividend support, with a risk/reward of roughly 2:1 toward the prior analyst target area versus a modest downside if flows cool.
• Sell covered calls against an existing IVZ long into strength over the next 4-6 weeks; the name has already rerated sharply, so option premium can monetize the market’s hesitation without fully exiting the structural earnings story.
• Pair trade: long IVZ / short a lower-quality active manager with weaker ETF exposure and less margin leverage, for the next earnings cycle; the spread should favor the cleaner flow mix if passive/ETF inflows remain dominant.
• If IVZ breaks below the recent post-earnings support, use put spreads rather than outright shorts; the downside catalyst is flow normalization, but capital returns and dividend support likely limit a sharp multi-month drawdown.
• Monitor the next two monthly flow reports; if ETF and international inflows remain positive, add to longs, but if they roll over, take profits quickly as the market is likely pricing a durable inflection that may not persist.